A Study of the Effect of a Disease-Specific Migraine Smart Phone Application (App) on Participant Care
Impact of Integrating a Disease-Specific Migraine App Into the Management of Patients in the Primary Care Setting
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Charlotte, North Carolina, United States, 28202
- Charlotte Internal Medicine
-
Charlotte, North Carolina, United States, 28203-5812
- Charlotte Medical Clinic
-
Charlotte, North Carolina, United States, 28210
- Carmel Family Physicians
-
Charlotte, North Carolina, United States, 28211
- Charlotte Medical Clinic-South Park
-
Charlotte, North Carolina, United States, 28211
- Randolph Internal Medicine
-
Charlotte, North Carolina, United States, 28226
- South Charlotte Primary Care
-
Charlotte, North Carolina, United States, 28277
- Mecklenburg Medical Group - Ballantyne
-
Glen Alpine, North Carolina, United States, 28628
- Table Rock Family Medicine
-
Huntersville, North Carolina, United States, 28078
- Mecklenburg Medical Group - Northcross
-
Huntersville, North Carolina, United States, 28078
- North Charlotte Medical Specialists - Huntersville
-
Lincolnton, North Carolina, United States, 28092
- Lincoln Family Practice
-
Matthews, North Carolina, United States, 28105
- Mecklenburg Medical Group - Matthews
-
Monroe, North Carolina, United States, 28112
- Union Family Practice
-
Troy, North Carolina, United States, 27371
- Troy Medical Services
-
-
South Carolina
-
Fort Mill, South Carolina, United States, 29715
- Shiland Family Fort Mill
-
Fort Mill, South Carolina, United States, 29715
- Shiland Family Practice
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Have a diagnosis of migraine (ICD10: G43.*) since October 2015 OR a record of being prescribed a triptan prior to study
- Have not been prescribed a preventive migraine medication within the past twelve months
- Have not visited a neurologist in the past year
- Have an upcoming visit with their Atrium Health primary care provider
Exclusion Criteria:
- Do not own an iOS or Android smart phone with a data plan or are unwilling to install the app on their phone
- Are currently participating in a clinical trial involving an investigational drug
- Have previously used the app used in this study
- Are pregnant at the time of study entry
- Are not able to provide informed consent
- Cannot speak and read English fluently
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Migraine Participants Using Application (App)
Participants with migraine history or a recent prescription for a common migraine medication will use a migraine app linked to their electronic health record (EHR) with results reported in their EHR.
|
Smart phone app used to report migraine burden to the EHR.
|
|
No Intervention: Controls Not Using App
Observational history on contemporaneous matched controls at similar sites without migraine app linked to their EHR.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Receiving a Preventive Migraine Prescription
Time Frame: Next primary care appointment following use of app (estimated as 5 weeks)
|
Number of Participants Receiving a Preventive Migraine Prescription
|
Next primary care appointment following use of app (estimated as 5 weeks)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Months of App Use
Time Frame: Baseline through one year
|
Number of Months of App Use
|
Baseline through one year
|
|
Number of Participants Receiving Acute and Preventive Migraine Treatments, Opioids, Barbiturates
Time Frame: Baseline through one year
|
Number of Participants Receiving Acute and Preventive Migraine Treatments, Opioids, Barbiturates
|
Baseline through one year
|
|
Number of Acute Care Visits
Time Frame: Baseline through one year
|
Number of Acute Care Visits
|
Baseline through one year
|
|
Number of Primary Care Visits
Time Frame: Baseline through one year
|
Number of Primary Care Visits
|
Baseline through one year
|
|
Number of Emergency Room Visits
Time Frame: Baseline through one year
|
Number of Emergency Room Visits
|
Baseline through one year
|
|
Number of Urgent Care Visits
Time Frame: Baseline through one year
|
Number of Urgent Care Visits
|
Baseline through one year
|
|
Number of Referrals to a Neurologist
Time Frame: Baseline through one year
|
Number of Referrals to a Neurologist
|
Baseline through one year
|
|
Number of New Diagnoses of Migraine or Chronic Migraine
Time Frame: Baseline through one year
|
Diagnoses made by International Classification of Diseases 10th revision (ICD10) coding system
|
Baseline through one year
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 17129
- I5Q-MC-CGBA (Other Identifier: Eli Lilly and Company)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.